Description:
Divalproex Sodium, consisting of a compound of sodium valproate and valproic acid in a 1:1 molar relationship in an enteric coated form, is a HDAC inhibitor used in the treatment of epilepsy. It acts via binding to and inhibiting gamma-aminobutyric acid (GABA) transaminase.
- Molecular Weight:310.41
- Melting Point:99-101°C
- Purity:>98%
Molecular Formula:
C16H31NaO4
Canonical SMILES:
CCCC(CCC)C(=O)O.CCCC(CCC)C(=O)[O-].[Na+]
InChI:
InChI=1S/2C8H16O2.Na/c2*1-3-5-7(6-4-2)8(9)10;/h2*7H,3-6H2,1-2H3,(H,9,10);/q;;+1/p-1
InChIKey:
MSRILKIQRXUYCT-UHFFFAOYSA-M
Solubility:
Soluble in Chloroform (Slightly), Methanol (Slightly)
Appearance:
White Solid
Application:
the treatment of epilepsy
Storage: Store at -20°C
Synonyms:
NSC 694279; NSC-694279; NSC694279; EP 475; EP475; EP-475; Valproate semisodium; Depakote; Epival; Depakote ER Weitere Informationen finden Sie
hier